CMS Says No Aduhelm Coverage for Patients Outside Clinical Trials

Retrieved on: 2022-04-08 16:00:22

Tags for this article:

Healthcare reform in the United States

Life Sciences

Health sciences

Health

Federal assistance in the United States

Presidency of Lyndon B. Johnson

Pharmaceutical industry

Liberalism in the United States

Medicare

Aducanumab

Biogen

National coverage determination

the centers for medicare and medicaid services

Click the tags to see associated articles and topics

CMS Says No Aduhelm Coverage for Patients Outside Clinical Trials. View article details on HISWAI: https://www.beingpatient.com/cms-officially-restricts-aduhelm-coverage-to-patients-in-clinical-trials/

Excerpt

The CMS finalized its controversial decision to limit the coverage of Alzheimer's drug Aduhelm and future monoclonal antibodies.

Article found on: www.beingpatient.com

View Original Article